Mylan Inc. (MYL) Ties Up With BioCon Limited (BIOCON.NS) for Insulin Marketing
2/14/2013 8:37:59 AM
More...
|
BioCon Limited (BIOCON.NS), Bristol-Myers Squibb Company (BMY) Sign Pact for Experimental Oral Insulin Drug
11/16/2012 7:46:49 AM
More...
|
BioCon Limited (BIOCON.NS) to Sell 7.69% of Research Unit to GE Capital for $23 Million
10/31/2012 8:03:04 AM
More...
|
BioCon Limited (BIOCON.NS) Close to Oral Insulin Deal With Bristol-Myers Squibb Company (BMY)
7/27/2012 7:41:31 AM
More...
|
BioCon Limited (BIOCON.NS) Opens Biologics Research Center; Will Hire 300 Scientists
4/6/2012 7:25:21 AM
More...
|
BioCon Limited (BIOCON.NS) Plunges After Pfizer Inc. (PFE) Scraps $350 Million Insulin Pact
3/13/2012 6:27:04 AM
More...
|
India's BioCon Limited Sees Oral Insulin Partner by March
11/23/2011 8:26:16 AM
More...
|
BioCon Limited Launches Haselmeier's Insulin Pen in India
11/22/2011 10:50:33 AM
More...
|
BioCon Limited Arm Inks Pact for Clinical Research with US Firm
8/22/2011 7:59:20 AM
More...
|
Bristol-Myers Squibb Company (BMY), Sanofi (France) (SASY.PA) in Race for Drug Marketing Pact with BioCon Limited; Sources Say BioCon Oral Insulin Drug Could be Worth $1 Billion to Suitors
6/14/2011 7:37:03 AM
More...
|
|